Published in Am J Med on May 20, 2010
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study. BMJ (2017) 1.73
Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. Neurology (2015) 1.62
Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology (2015) 1.42
Increased risk of hemorrhagic stroke in patients with migraine: a population-based cohort study. PLoS One (2013) 0.95
Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol (2014) 0.93
Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies. Neuroepidemiology (2012) 0.90
Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ (2016) 0.89
Migraine and stroke: "vascular" comorbidity. Front Neurol (2014) 0.87
Risk of Stroke in Migraineurs Using Triptans. Associations with Age, Sex, Stroke Severity and Subtype. EBioMedicine (2016) 0.85
Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? J Headache Pain (2013) 0.83
Migraine in perimenopausal women. Neurol Sci (2015) 0.82
Migraine and estrogen. Curr Opin Neurol (2014) 0.82
Trimester-specific blood pressure levels and hypertensive disorders among pregnant migraineurs. Headache (2011) 0.82
The Migraine-Stroke Connection. J Stroke (2016) 0.82
Migraine in menopausal women: a systematic review. Int J Womens Health (2015) 0.80
Migraine and risk of stroke in older adults: Northern Manhattan Study. Neurology (2015) 0.79
Migraine with aura: which patients are most at risk of stroke? Neurol Sci (2015) 0.79
Stroke and Stroke-Like Symptoms in Patients with Mutations in the POLG1 Gene. JIMD Rep (2011) 0.78
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol (2016) 0.78
Transient ischemic attack requiring hospitalization of children in the United States: kids' inpatient database 2003 to 2009. Stroke (2014) 0.78
Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies. Neurol Sci (2016) 0.78
Is migraine a risk factor for pediatric stroke? Cephalalgia (2015) 0.78
"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism. Postepy Kardiol Interwencyjnej (2014) 0.77
Migraine and hemorrhagic stroke: data from general practice. J Headache Pain (2015) 0.76
Prevention opportunities for oral contraceptive-associated ischemic stroke. Stroke (2014) 0.76
Evaluation of carotid intima-media thickness in children with migraine: a marker of subclinical atherosclerosis. Neurol Sci (2016) 0.76
Polymorphisms in migraine-associated gene, atp1a2, and ischemic stroke risk in a biracial population: the genetics of early onset stroke study. Springerplus (2013) 0.76
Meta-analysis of results from case control and cohort studies finds that migraine is associated with approximately twice the risk of ischaemic stroke. Evid Based Med (2010) 0.76
The potential impact of primary headache disorders on stroke risk. J Headache Pain (2016) 0.75
CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships. PLoS One (2016) 0.75
Migraine and Stroke: What's the Link? What to Do? Curr Neurol Neurosci Rep (2017) 0.75
The relationship between right-to-left shunt and brain white matter lesions in Japanese patients with migraine: a single center study. J Headache Pain (2017) 0.75
Stroke, Migraine and Triptans: From Bedside to Bench. EBioMedicine (2016) 0.75
High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients. J Headache Pain (2015) 0.75
Is migraine a modifiable risk factor for ischemic stroke? Potentially not. Am J Med (2011) 0.75
Fasting lipid and lipoproteins concentrations in pregnant women with a history of migraine. Headache (2015) 0.75
Does a history of migraine affect the rate of thrombolysis in young stroke patients? Stroke Res Treat (2013) 0.75
Statins for all: should patients who have migraine with aura be on a statin? Br J Gen Pract (2015) 0.75
Ischemic stroke subtypes and migraine with visual aura in the ARIC study. Neurology (2016) 0.75
Increased Risk of Stroke in Patients With Fibromyalgia: A Population-BASED Cohort Study. Medicine (Baltimore) (2016) 0.75
Migraine and risk of stroke and acute coronary syndrome in two case-control studies in the Danish population. Clin Epidemiol (2017) 0.75
Juvenile Stroke. Dtsch Arztebl Int (2017) 0.75
Shared genetic risk between migraine and coronary artery disease: A genome-wide analysis of common variants. PLoS One (2017) 0.75
Migraine with aura and white matter lesions: an MRI study. Neurol Sci (2017) 0.75
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
The International Classification of Headache Disorders: 2nd edition. Cephalalgia (2004) 49.94
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol (2003) 7.05
Migraine prevalence, disease burden, and the need for preventive therapy. Neurology (2007) 6.57
Prevalence of patent foramen ovale in patients with stroke. N Engl J Med (1988) 5.94
Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med (2006) 5.61
Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol (1984) 5.21
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke (1990) 3.43
Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ (2004) 2.86
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ (1997) 2.83
The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol (1998) 2.72
Migraine and risk of cardiovascular disease in men. Arch Intern Med (2007) 2.49
Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke (2007) 2.43
Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J (2008) 2.36
Migraine prevalence. A review of population-based studies. Neurology (1994) 2.34
Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol (2006) 2.31
Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology (2005) 2.31
Case-control study of migraine and risk of ischaemic stroke in young women. BMJ (1995) 2.03
Migraine, headache, and the risk of stroke in women: a prospective study. Neurology (2005) 2.01
Migraine and risk of ischaemic stroke: a case-control study. BMJ (1993) 1.79
Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynaecol (1995) 1.76
A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol (1989) 1.71
Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol (1997) 1.58
Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology (2004) 1.58
Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke (2003) 1.49
Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology (1993) 1.40
Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol (1995) 1.40
History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet (1996) 1.32
Oral contraceptives and stroke in young women. Associated risk factors. JAMA (1975) 1.32
Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry (2002) 1.32
Ischemic stroke in young women: a nested case-control study using the UK General Practice Research Database. Stroke (2004) 1.22
The association between migraine and juvenile stroke: a case-control study. Headache (2003) 1.12
Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control study. Eur J Neurol (2004) 1.12
Increased von Willebrand factor in migraine. Neurology (2001) 1.05
Stroke in pregnancy. Semin Neurol (2007) 1.04
Severe vascular events in migraine patients. Headache (2004) 1.04
Migraine and stroke: current perspectives. Neurol Res (2008) 1.02
Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache (2007) 0.99
A history of migraine is not a risk factor to develop an ischemic stroke in the elderly. Headache (2001) 0.99
Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception (2002) 0.98
Lifestyle-associated risk factors for acute brain infarction among persons of working age. Stroke (1997) 0.96
Endothelin 1 in migraine and tension-type headache. Acta Neurol Scand (1994) 0.96
Evidence for activation of the coagulation system in migraine with aura. Cephalalgia (2001) 0.95
Migraine and stroke: the role of oral contraceptives. Neurol Sci (2008) 0.93
Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura. J Neurol Neurosurg Psychiatry (1994) 0.91
Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry (2004) 0.90
From migraine to stroke. Intern Emerg Med (2008) 0.87
Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception (2005) 0.86
Hormonal management of migraine at menopause. Menopause Int (2009) 0.84
Use of oral contraceptives and postmenopausal hormone replacement: evidence on risk of stroke. Curr Treat Options Neurol (2008) 0.82
Recognition and treatment of menstrual migraine. Neurologist (2007) 0.82
Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases. Rom J Intern Med (2007) 0.80
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.55
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med (2013) 3.40
End-stage renal disease predicts complications in pacemaker and ICD implants. J Cardiovasc Electrophysiol (2011) 3.21
Feasibility of image-based simulation to estimate ablation target in human ventricular arrhythmia. Heart Rhythm (2013) 2.42
Characterization of acute and subacute radiofrequency ablation lesions with nonenhanced magnetic resonance imaging. Heart Rhythm (2006) 2.17
Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life. J Vasc Surg (2003) 2.10
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med (2013) 2.09
Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res (Hoboken) (2014) 2.09
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation (2006) 2.07
Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2006) 2.05
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol (2010) 1.97
Does left atrial volume and pulmonary venous anatomy predict the outcome of catheter ablation of atrial fibrillation? J Cardiovasc Electrophysiol (2009) 1.84
Thrombophilic disorders and fetal loss: a meta-analysis. Lancet (2003) 1.81
Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.75
Investigating socio-economic disparities in preterm birth: evidence for selective study participation and selection bias. Paediatr Perinat Epidemiol (2009) 1.75
Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2009) 1.74
Cardiac magnetic resonance T1 mapping of left atrial myocardium. Heart Rhythm (2013) 1.73
The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost (2005) 1.72
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72
The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging. Heart Rhythm (2011) 1.71
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ (2008) 1.71
T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med (2010) 1.68
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation (2014) 1.64
Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences. J Magn Reson Imaging (2011) 1.59
Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res (2007) 1.58
Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study. Lancet Oncol (2007) 1.57
The occurrence of venous thromboembolism in cancer patients following major surgery. Thromb Res (2012) 1.53
High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol (2012) 1.53
Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial. Thromb Haemost (2008) 1.50
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study. Thromb Haemost (2013) 1.47
Evaluation of cardiac arrhythmia among athletes. Am J Med (2010) 1.45
Arsenic exposure and hypertension: a systematic review. Environ Health Perspect (2011) 1.44
Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.44
Novel electrode design for potentially painless internal defibrillation also allows for successful external defibrillation. J Cardiovasc Electrophysiol (2007) 1.41
Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm (2011) 1.28
The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res (2005) 1.27
Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol (2009) 1.27
Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med (2013) 1.22
Reduction of secondhand tobacco smoke in public places following national smoke-free legislation in Uruguay. Tob Control (2010) 1.20
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica (2010) 1.20
Transoesophageal echocardiography predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. Europace (2010) 1.18
The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med (2002) 1.15
Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birth. Cytokine (2009) 1.15
Fatal outcome of a calcified amorphous tumor of the heart (cardiac CAT). Cardiovasc Pathol (2006) 1.14
Long-term safety and efficacy of circumferential ablation with pulmonary vein isolation. J Cardiovasc Electrophysiol (2006) 1.13
Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc Imaging (2011) 1.10
Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm (2012) 1.09
Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery. CMAJ (2008) 1.07
Cadmium exposure and clinical cardiovascular disease: a systematic review. Curr Atheroscler Rep (2013) 1.05
Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest (2005) 1.05
Predictors of high defibrillation threshold in the modern era. Pacing Clin Electrophysiol (2012) 1.05
A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2009) 1.05
Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm (2010) 1.04
Effects of surgical and endoscopic electrocautery on modern-day permanent pacemaker and implantable cardioverter-defibrillator systems. Pacing Clin Electrophysiol (2008) 1.04
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest (2009) 1.03
Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol (2006) 1.03
Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm (2013) 1.03
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood (2008) 1.03
Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study. Circ Arrhythm Electrophysiol (2014) 1.02
Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol (2012) 1.01
Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol (2003) 0.99
Myocardial structural associations with local electrograms: a study of postinfarct ventricular tachycardia pathophysiology and magnetic resonance-based noninvasive mapping. Circ Arrhythm Electrophysiol (2012) 0.98
Association of QRS duration with left ventricular structure and function and risk of heart failure in middle-aged and older adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Eur J Heart Fail (2012) 0.97
Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials. Chest (2012) 0.95
Intra- and interobserver agreement and statistical clustering of placental histopathologic features relevant to preterm birth. Am J Obstet Gynecol (2006) 0.95
Secondhand smoke exposure in bars and restaurants in Guatemala City: before and after smoking ban evaluation. Cancer Causes Control (2010) 0.95
Predictive value of obstructive sleep apnoea assessed by the Berlin Questionnaire for outcomes after the catheter ablation of atrial fibrillation. Europace (2009) 0.94
Levels of inflammatory markers and the development of the post-thrombotic syndrome. Thromb Haemost (2009) 0.94
Effects of external electrical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice. Circulation (2013) 0.93
Development of a research agenda for inferior vena cava filters: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2009) 0.93
Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database. Pharmacoepidemiol Drug Saf (2010) 0.93
Internal medicine residency training on topics in ambulatory care: a status report. Am J Med (2011) 0.93
Demographic profile of patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2011) 0.91
Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial. Heart Rhythm (2010) 0.89
Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2009) 0.89
Long- and short-term temporal stability of complex fractionated atrial electrograms in human left atrium during atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.89
Direct imaging of transvenous radiofrequency cardiac ablation using a steerable fiberoptic infrared endoscope. Heart Rhythm (2005) 0.88
Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol (2013) 0.87
Vasculopathic and thrombophilic risk factors for spontaneous preterm birth. Int J Epidemiol (2009) 0.87
Outcomes in patients requiring cardioversion following catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2009) 0.87
Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Heart Rhythm (2012) 0.86
Circumferential ablation with pulmonary vein isolation in permanent atrial fibrillation. Am J Cardiol (2007) 0.86
Impact of heart rhythm status on registration accuracy of the left atrium for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2007) 0.86
Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patients. Am J Cardiovasc Drugs (2004) 0.86
Real-time percutaneous optical imaging of anatomical structures in the heart through blood using a catheter-based infrared imaging system. Semin Thorac Cardiovasc Surg (2007) 0.85
Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythm Electrophysiol (2014) 0.83
Long-term prognosis after deep venous thrombosis. Curr Opin Hematol (2008) 0.83
The effect of anticoagulants on cancer risk and survival: systematic review. Cancer Treat Rev (2007) 0.83
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb Haemost (2010) 0.83
Maternal lipids and small for gestational age birth at term. J Pediatr (2013) 0.83
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery. Pharmacoeconomics (2003) 0.82
Cardiovascular magnetic resonance for risk stratification of arrhythmia in hypertrophic cardiomyopathy. J Am Coll Cardiol (2008) 0.82
Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial. Thromb Haemost (2014) 0.81